This round sell off after patient dosing would probably be not that strong as before. Sellers will be selling into bids by buyers positioning themselves to be long for positive result from third patient that is dosed at 300% higher dosage than the second patient.
- Forums
- ASX - By Stock
- BLT
- Ann: SAN FRANCISCO BIOTECH PRESENTATION
Ann: SAN FRANCISCO BIOTECH PRESENTATION, page-10
-
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online